Journal of General Internal Medicine

, Volume 27, Issue 12, pp 1714–1720 | Cite as

Usability of FDA-Approved Medication Guides

  • Michael S. Wolf
  • Jennifer King
  • Elizabeth A. H. Wilson
  • Laura M. Curtis
  • Stacy Cooper Bailey
  • James Duhig
  • Allison Russell
  • Ashley Bergeron
  • Amanda Daly
  • Ruth M. Parker
  • Terry C. Davis
  • William H. Shrank
  • Bruce Lambert
Original Research

Abstract

BACKGROUND

Medication guides are required documents to be distributed to patients in order to convey serious risks associated with certain prescribed medicines. Little is known about the effectiveness of this information to adequately inform patients on safe use.

OBJECTIVE

To examine the readability, suitability, and comprehensibility of medication guides, particularly for those with limited literacy.

DESIGN

Assessments of suitability and readability of 185 medication guides, and a sub-study examining change in suitability and readability from 2006 to 2010 among 32 of the medication guides (Study 1); ‘open book’ comprehension assessment of medication guides (Study 2).

SETTING

Two general internal medicine clinics in Chicago, IL.

PATIENTS

Four hundred and forty-nine adults seeking primary care services, ages 18–85.

MEASUREMENTS

For Study 1, the Suitability Assessment of Materials (SAM) and Lexile score for readability. For Study 2, a tailored comprehension assessment of content found in three representative medication guides.

RESULTS

The 185 analyzed medication guides were on average 1923 words (SD = 1022), with a mean reading level of 10–11th grade. Only one medication guide was deemed suitable in SAM analyses. None provided summaries or reviews, or framed the context first, while very few were rated as having made the purpose evident (8 %), or limited the scope of content (22 %). For Study 2, participants’ comprehension of medication guides was poor (M = 52.7 % correct responses, SD = 22.6). In multivariable analysis, low and marginal literacy were independently associated with poorer understanding (β = –14.3, 95 % CI –18.0 – –10.6, p < 0.001; low: β = –23.7, 95 % CI –28.3 – –19.0, p < 0.001).

CONCLUSION

Current medication guides are of little value to patients, as they are too complex and difficult to understand especially for individuals with limited literacy. Explicit guidance is offered for improving these print materials.

KEY WORDS

prescription medication information comprehension FDA medication guide health literacy 

Notes

Acknowledgments

This project was supported by an unrestricted grant from Abbott Labs (PI: Wolf).

Conflict of Interest

Drs. Wolf and Bailey have served as paid consultants to Abbott Labs for research services and advisory committee activities. Both Drs. Davis and Wolf have served as paid consultants to McNeil Consumer Healthcare in service for advisory board membership on drug labeling initiatives.

Competing Interests

Drs. Wolf, Davis, and Lambert have previously provided research consultation services to Abbott Labs.

Supplementary material

11606_2012_2068_MOESM1_ESM.doc (47 kb)
ESM 1 (DOC 47 kb)

References

  1. 1.
    Department of Health and Human Services. Prescription Drug Product Labeling: medication guide Requirements; Final Rule. Fed Regist. 1998;63:66378–400.Google Scholar
  2. 2.
    Department of Health and Human Services. medication guides for Prescription Drug Products. Title 21 Code of Federal Regulations. Pt. 208. 2004:115-6.Google Scholar
  3. 3.
    U.S. Food and Drug Administration. Guidance for Industry: Format and Content of Proposed Risk Evaluation and Mitigation Strategies (REMS), REMS Assessments and Proposed REMS Modifications. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM184128.pdf. Accessed March 29, 2012
  4. 4.
    U.S. Food and Drug Administration, Center for Drug Evaluation Research (CDER). Guidance for Industry: medication guides - Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM244570.pdf. Accessed March 29, 2012.
  5. 5.
    Stubbings J, Joshi RA, Hoffman JM. Risk evaluation and mitigation strategies: challenges and opportunities for health-system pharmacists. Am J Health Syst Pharm. 2010;67:1547–54.PubMedCrossRefGoogle Scholar
  6. 6.
    Hennessy KF, Williams KG, Bongero D. Safer use of medications through risk evaluation and mitigation strategies: Academy perspectives. J Am Pharm Assoc (2003). 2010;50:556-62.Google Scholar
  7. 7.
    Morris LA, Tabak ER, Gondek K. Counseling patients about prescribed medication: 12-year trends. Med Care. 1997;35:996–1007.PubMedCrossRefGoogle Scholar
  8. 8.
    Metlay JP, Cohen A, Polsky D, Kimmel SE, Koppel R, Hennessy S. Medication safety in older adults: home-based practice patterns. J Am Geriatr Soc. 2005;53:976–82.PubMedCrossRefGoogle Scholar
  9. 9.
    Sleath B, Roter D, Chewning B, Svarstad B. Asking questions about medication: analysis of physician-patient interactions and physician perceptions. Med Care. 1999;37:1169–73.PubMedCrossRefGoogle Scholar
  10. 10.
    Stevenson FA, Cox K, Britten N, Dundar Y. A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expect. 2004;7:235–45.PubMedCrossRefGoogle Scholar
  11. 11.
    Allen LaPointe NM, Pappas P, Deverka P, Anstrom KJ. Patient receipt and understanding of written information provided with isotretinoin and estrogen prescriptions. J Gen Intern Med. 2007;22:98-101.Google Scholar
  12. 12.
    Wolf MS, Davis TC, Shrank WH, Neuberger M, Parker RM. A critical review of FDA-approved medication guides. Patient Educ Couns. 2006;62:316–22.PubMedCrossRefGoogle Scholar
  13. 13.
    Wallace LS, Roskos S, Weiss BD. Readability characteristics of consumer medication information for asthma inhalation devices. J Asthma. 2006;43:375–8.PubMedCrossRefGoogle Scholar
  14. 14.
    The Keystone National Policy Dialogue on Food. Nutrition, and Health: The Final Report. Keystone: The Keystone Center; 1996.Google Scholar
  15. 15.
    Shrank WH, Agnew-Blais J, Choudhry NK, et al. The variability and quality of medication container labels. Arch Intern Med. 2007;167:1760–5.PubMedCrossRefGoogle Scholar
  16. 16.
    U.S. Food and Drug Administration. Public Hearing on Use of medication guides to Distribute Drug Risk Information. Washington, DC; June 12-13, 2007.Google Scholar
  17. 17.
    U.S. Food and Drug Administration. Providing Effective Information to Consumers About Prescription Drug Risks and Benefits. Public Workshop. Gaithersburg, MD; September 24-25, 2009.Google Scholar
  18. 18.
    Department of Health and Human Services. Experimental Study of Patient Information Prototypes. Fed Regist. 2010;75:78252–6.Google Scholar
  19. 19.
    Brookings Institution. The Science of Communicating Medication Information to Consumers. An Engelberg Center for Healthcare Reform Event. Washington DC; July 21, 2010.Google Scholar
  20. 20.
    Doak CC, Doak LG, Root JH. Assessing Suitability of Materials. Teaching Patients with Low Literacy Skills. 2nd ed. Philadelphia: JB Lippincott; 1996.Google Scholar
  21. 21.
    Lennon C, Burdick H. The Lexile Framework as an Approach for Reading Measurement and Success. Durham: MetaMetrics, Inc.; 2004.Google Scholar
  22. 22.
    Wolf MS, Shekelle P, Choudhry NK, Agnew-Blais J, Parker RM, Shrank WH. Variability in pharmacy interpretations of physician prescriptions. Med Care. 2009;47:370–3.PubMedCrossRefGoogle Scholar
  23. 23.
    Callahan CM, Unverzagt FW, Hui SL, Perkins AJ, Hendrie HC. Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med Care. 2002;40:771–81.PubMedCrossRefGoogle Scholar
  24. 24.
    Davis TC, Long SW, Jackson RH, et al. Rapid estimate of adult literacy in medicine: a shortened screening instrument. Fam Med. 1993;25:391.PubMedGoogle Scholar
  25. 25.
    U.S. Food and Drug Administration, Center for Drug Evaluation Research (CDER). medication guides. http://www.fda.gov/drugs/drugsafety/UCM085729.htm. Accessed March 29, 2012.
  26. 26.
    Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein AM. Promotion of prescription drugs to consumers. Vol. 2002;346:498–505.Google Scholar
  27. 27.
    Krass I, Svarstad BL, Bultman D. Using alternative methodologies for evaluating patient medication leaflets. Patient Educ Couns. 2002;47:29–35.PubMedCrossRefGoogle Scholar
  28. 28.
    Gustafsson J, Kälvemark S, Nilsson G, Nilsson JLG. Patient information leaflets—patients’ comprehension of information about interactions and contraindications. Pharm World Sci. 2005;27:35–40.PubMedCrossRefGoogle Scholar
  29. 29.
    Plain Language Action and Information Network (PLAIN). Improving Communcation from the Federal Government to the Public. Plain Language: It's the law http://www.plainlanguage.gov/plLaw/index.cfm. Accessed March 29, 2012.
  30. 30.
    National Work Group on Literacy and Health. Communicating with patients who have limited literacy skills: Report of the National Work Group on Literacy and Health. J Fam Pract. 1998;46:168–76.Google Scholar
  31. 31.
    Agency for Healthcare Research and Quality (AHRQ). Contract HHSA2902009000121: Educational tools and resources to support meaningful use of electronic health records (Abt Associates).Google Scholar
  32. 32.
    Institute of Medicine. Health literacy: A prescription to end confusion. Washington DC: National Academy Press; 2004.Google Scholar
  33. 33.
    Wolf MS, Davis TC, Tilson HH, Bass PF 3rd, Parker RM. Misunderstanding of prescription drug warning labels among patients with low literacy. Am J Health Syst Pharm. 2006;63:1048–55.PubMedCrossRefGoogle Scholar
  34. 34.
    Davis TC, Wolf MS, Bass PF 3rd, et al. Low literacy impairs comprehension of prescription drug warning labels. J Gen Intern Med. 2006;21:847–51.PubMedCrossRefGoogle Scholar
  35. 35.
    Davis TC, Wolf MS, Bass PF 3rd, et al. Literacy and misunderstanding prescription drug labels. Ann Intern Med. 2006;145:887–94.PubMedGoogle Scholar
  36. 36.
    Wilson E, Chen AH, Grumbach K, Wang F, Fernandez A. Effects of limited English proficiency and physician language on health care comprehension. J. Gen. Intern. Med. 2005;20(9):800–6.PubMedCrossRefGoogle Scholar
  37. 37.
    Sharif I, Tse J. Accuracy of Computer-Generated, Spanish-Language Medicine Labels. Pediatrics 2010;125(5):960–965.Google Scholar
  38. 38.
    Leyva M, Sharif I, Ozuah PO. Health literacy among Spanish-speaking Latino parents with limited English proficiency. Ambul Pediatr. 2005;5(1):56–9.PubMedCrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 2012

Authors and Affiliations

  • Michael S. Wolf
    • 1
    • 2
  • Jennifer King
    • 1
  • Elizabeth A. H. Wilson
    • 1
  • Laura M. Curtis
    • 1
  • Stacy Cooper Bailey
    • 1
  • James Duhig
    • 3
  • Allison Russell
    • 1
  • Ashley Bergeron
    • 1
  • Amanda Daly
    • 1
  • Ruth M. Parker
    • 4
  • Terry C. Davis
    • 5
  • William H. Shrank
    • 6
  • Bruce Lambert
    • 3
  1. 1.Health Literacy and Learning Program, Division of General Internal MedicineFeinberg School of Medicine at Northwestern UniversityChicagoUSA
  2. 2.Department of Learning Sciences, School of Education and Social PolicyNorthwestern UniversityEvanstonUSA
  3. 3.Department of Pharmacy AdministrationUniversity of Illinois at Chicago College of PharmacyChicagoUSA
  4. 4.Division of General MedicineEmory University School of MedicineAtlantaUSA
  5. 5.Department of Medicine-PediatricsLouisiana State University Health Sciences CenterShreveportUSA
  6. 6.Brigham and Women’s HospitalHarvard Medical SchoolBostonUSA

Personalised recommendations